India is rapidly establishing itself as a global hub for neutraceutical active pharmaceutical ingredient development, driven by a combination of factors including competitive rates, a skilled labor pool, and supportive government initiatives. Numerous companies are now focusing on the synthesis and distribution of these crucial compounds used in di